Background: To investigate the value of fluid-attenuated inversion recovery (FLAIR) Vascular Hyperintensity (FVH) in predicting early neurological deterioration (END) and short-term prognosis in acute ischemic stroke (AIS) patients who beyond the time window for recanalization therapy Methods: We retrospectively analyzed the AIS patients from 24 to 72 hours after symptom onset, who received dual antiplatelet therapy (DAPT). The patients were divided into the END and no early neurological deterioration (NEND) group according to the change of the National Institutes of Health Stroke Scale (NIIISS) score. Trhe patients were also divided into the favorable and unfavorable prognosis group according to the 90 day modified Rankin Scale (mRS). The Alberta Stroke Program Early CT Score (ASPECTS) was used to assess the scope of infarction on DWI; the modified ASPECTS was used to assess the presence of EVII on FLAIR and multiple hypointense vessels (MHV) on SWI. We performed binary stepwise regression analysis with END and short-term prognosis as dependent variables to evaluate the odds ratio (OR) and its 95% confidence interval (CI) of primary outcomes. Next, we sequentially excluded nonsignificant variables from the last model to determine the risk factors of END. Results: Two-hundred sixty-seven patients were included in this study. The median NIHSS score at admission was 6 iinterquartile range (IQR) 5, 9], the median DWI-ASPECTS at admission was 8 (IQR 6, 9), the median EVII score was 7 (IQR 3, 7), and the median Mt fV-AS PECTS was 8 (IQR 6, 8). Tlfhe NIHSS score at admission was higher in the END group. The AIFIV-ASPECTS, DWI-ASPECTS, and FVH-ASPECTS were lower in the END group. Binary stepwise regression analysis showed that the FVHASPECTS (OR =0.39, 95% CI: 0.1744).872) and vascular stenosis/occlusion (OR =0.015, 95% CI: 0.0000.943) were independent risk factors of END. Conclusions; For AIS patients beyond the time window for recanalization therapy who are receiving DAFT, a low FA/II-ASPECTS is associated with a higher risk of END. In patients with vascular occlusion/ stenosis, FVH may be used as a predictor of END and an unfavorable 90-day prognosis in patients beyond the time window for recanalization therapy who are receiving a-WT.
机构:
Yonsei Univ, Coll Med, Dept Radiol, Seoul 135720, South Korea
Yonsei Univ, Severance Inst Vasc & Metab Res, Seoul 135720, South KoreaYonsei Univ, Coll Med, Dept Radiol, Seoul 135720, South Korea
Suh, S. H.
;
Lee, K. -Y.
论文数: 0引用数: 0
h-index: 0
机构:
Yonsei Univ, Coll Med, Dept Neurol, Seoul 135720, South Korea
Yonsei Univ, Severance Inst Vasc & Metab Res, Seoul 135720, South KoreaYonsei Univ, Coll Med, Dept Radiol, Seoul 135720, South Korea
Lee, K. -Y.
;
Kim, J. H.
论文数: 0引用数: 0
h-index: 0
机构:
Yonsei Univ, Coll Med, Dept Neurol, Seoul 135720, South KoreaYonsei Univ, Coll Med, Dept Radiol, Seoul 135720, South Korea
Kim, J. H.
;
Seo, K. -D.
论文数: 0引用数: 0
h-index: 0
机构:
Yonsei Univ, Coll Med, Dept Neurol, Seoul 135720, South KoreaYonsei Univ, Coll Med, Dept Radiol, Seoul 135720, South Korea
Seo, K. -D.
;
Lee, S.
论文数: 0引用数: 0
h-index: 0
机构:
GE Healthcare, Global Applicat & Workflow, Seoul, South KoreaYonsei Univ, Coll Med, Dept Radiol, Seoul 135720, South Korea
机构:
Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USAUniv So Calif, Dept Neurol, Los Angeles, CA 90033 USA
Azizyan, A.
;
Sanossian, N.
论文数: 0引用数: 0
h-index: 0
机构:
Univ So Calif, Dept Neurol, Los Angeles, CA 90033 USA
Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USAUniv So Calif, Dept Neurol, Los Angeles, CA 90033 USA
Sanossian, N.
;
Mogensen, M. A.
论文数: 0引用数: 0
h-index: 0
机构:
Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA
Univ So Calif, Dept Radiol, Los Angeles, CA 90033 USAUniv So Calif, Dept Neurol, Los Angeles, CA 90033 USA
Mogensen, M. A.
;
Liebeskind, D. S.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA
Univ Calif Los Angeles, Stroke Ctr, Los Angeles, CA 90024 USAUniv So Calif, Dept Neurol, Los Angeles, CA 90033 USA
机构:
Yonsei Univ, Coll Med, Dept Radiol, Seoul 135720, South Korea
Yonsei Univ, Severance Inst Vasc & Metab Res, Seoul 135720, South KoreaYonsei Univ, Coll Med, Dept Radiol, Seoul 135720, South Korea
Suh, S. H.
;
Lee, K. -Y.
论文数: 0引用数: 0
h-index: 0
机构:
Yonsei Univ, Coll Med, Dept Neurol, Seoul 135720, South Korea
Yonsei Univ, Severance Inst Vasc & Metab Res, Seoul 135720, South KoreaYonsei Univ, Coll Med, Dept Radiol, Seoul 135720, South Korea
Lee, K. -Y.
;
Kim, J. H.
论文数: 0引用数: 0
h-index: 0
机构:
Yonsei Univ, Coll Med, Dept Neurol, Seoul 135720, South KoreaYonsei Univ, Coll Med, Dept Radiol, Seoul 135720, South Korea
Kim, J. H.
;
Seo, K. -D.
论文数: 0引用数: 0
h-index: 0
机构:
Yonsei Univ, Coll Med, Dept Neurol, Seoul 135720, South KoreaYonsei Univ, Coll Med, Dept Radiol, Seoul 135720, South Korea
Seo, K. -D.
;
Lee, S.
论文数: 0引用数: 0
h-index: 0
机构:
GE Healthcare, Global Applicat & Workflow, Seoul, South KoreaYonsei Univ, Coll Med, Dept Radiol, Seoul 135720, South Korea
机构:
Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USAUniv So Calif, Dept Neurol, Los Angeles, CA 90033 USA
Azizyan, A.
;
Sanossian, N.
论文数: 0引用数: 0
h-index: 0
机构:
Univ So Calif, Dept Neurol, Los Angeles, CA 90033 USA
Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USAUniv So Calif, Dept Neurol, Los Angeles, CA 90033 USA
Sanossian, N.
;
Mogensen, M. A.
论文数: 0引用数: 0
h-index: 0
机构:
Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA
Univ So Calif, Dept Radiol, Los Angeles, CA 90033 USAUniv So Calif, Dept Neurol, Los Angeles, CA 90033 USA
Mogensen, M. A.
;
Liebeskind, D. S.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA
Univ Calif Los Angeles, Stroke Ctr, Los Angeles, CA 90024 USAUniv So Calif, Dept Neurol, Los Angeles, CA 90033 USA